In conclusion, the in vivo mouse models demonstrated that AST could inhibit caspase‐9 and caspase‐3 expression by activating p‐AKT to help improve COPD‐induced diaphragm apoptosis, alleviate diaphragmatic fatigue, and reduce the risk of respiratory failure. Here, AKT1 is linked to chronic obstructive pulmonary disease.